These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 8228579
1. Plasma reactivity to hexagonal II phase phosphatidylethanolamine is more frequently associated with lupus anticoagulant than with antiphosphatidylethanolamine antibodies. Berard M, Boffa MC, Karmochkine M, Aillaud MF, Juhan-Vague I, Francès C, Cacoub P, Piette JC, Harlé JR. J Lab Clin Med; 1993 Nov; 122(5):601-5. PubMed ID: 8228579 [Abstract] [Full Text] [Related]
3. Inhibition of lupus anticoagulant activity by hexagonal phase phosphatidylethanolamine in the presence of prothrombin. Rauch J, Tannenbaum M, Neville C, Fortin PR. Thromb Haemost; 1998 Dec; 80(6):936-41. PubMed ID: 9869164 [Abstract] [Full Text] [Related]
4. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants; association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease. Drouvalakis KA, Buchanan RR. J Rheumatol; 1998 Feb; 25(2):290-5. PubMed ID: 9489821 [Abstract] [Full Text] [Related]
5. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC. J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [Abstract] [Full Text] [Related]
6. [Antiphospholipid antibodies: clinical significance and biological diagnosis]. Arnoux D, Boutière B, Sanmarco M. Ann Biol Clin (Paris); 2000 Apr; 58(5):557-74. PubMed ID: 11022099 [Abstract] [Full Text] [Related]
14. Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus. Karmochkine M, Berard M, Piette JC, Cacoub P, Aillaud MF, Harlé JR, Godeau P, Boffa MC, Harlet JR. Lupus; 1993 Jun 01; 2(3):157-60. PubMed ID: 8369806 [Abstract] [Full Text] [Related]
15. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity. Boffa MC, Berard M, Sugi T, McIntyre JA. J Rheumatol; 1996 Aug 01; 23(8):1375-9. PubMed ID: 8856616 [Abstract] [Full Text] [Related]
16. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome. Kandiah DA, Krilis SA. Thromb Haemost; 1998 Aug 01; 80(2):250-7. PubMed ID: 9716148 [Abstract] [Full Text] [Related]
17. [Phospholipid antibodies (lupus anticoagulant and cardiolipin antibodies). Detection and clinical significance]. Wisløff F, Sletnes KE, Schjetlein R. Tidsskr Nor Laegeforen; 1993 Aug 10; 113(18):2269-72. PubMed ID: 8362396 [Abstract] [Full Text] [Related]
18. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases. Berard M, Chantome R, Marcelli A, Boffa MC. J Rheumatol; 1996 Aug 10; 23(8):1369-74. PubMed ID: 8856615 [Abstract] [Full Text] [Related]
19. Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). Bidot CJ, Jy W, Horstman LL, Ahn ER, Yaniz M, Ahn YS. Am J Hematol; 2006 Jun 10; 81(6):391-6. PubMed ID: 16680753 [Abstract] [Full Text] [Related]
20. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications. Nojima J, Suehisa E, Kuratsune H, Machii T, Koike T, Kitani T, Kanakura Y, Amino N. Thromb Haemost; 1999 Mar 10; 81(3):436-41. PubMed ID: 10102474 [Abstract] [Full Text] [Related] Page: [Next] [New Search]